Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes

被引:7
作者
Okazaki, Kentaro [1 ]
Shingaki, Tomotaka [2 ]
Cai, Zhihong [2 ]
Perez-Nieves, Magaly [3 ]
Fisher, Lawrence [4 ]
机构
[1] Nagoya Univ, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[2] Eli Lilly Japan KK, Chuo Ku, 5-1-28 Isogami Dori, Kobe, Hyogo 6510086, Japan
[3] Eli Lilly & Co, 1555 S Harding St, Indianapolis, IN 46221 USA
[4] Behav Diabet Inst, 5405 Oberlin Dr Suite 100, San Diego, CA 92121 USA
关键词
Insulin; Japan; Psychological insulin resistance; Type 2 diabetes mellitus; INITIATION; THERAPY; PEOPLE; ATTITUDES; BARRIERS; WISHES; SCOPE;
D O I
10.1007/s13300-019-0664-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plain Language Summary The increasing prevalence of type 2 diabetes mellitus (T2D) is a major health concern globally. In Japan, the prevalence of diabetes is predicted to increase over the next decades. Insulin is a hormone which keeps blood glucose levels within the normal range. People with diabetes often require insulin therapy as they do not make sufficient insulin, or the insulin that is produced does not work optimally. Many patients delay insulin therapy due to a variety of factors. Reluctance to begin insulin treatment is known as 'psychological insulin resistance' (PIR). Several studies have described recommendations to address PIR, but there is little research regarding effective strategies that help reluctant patients begin insulin. Reports describing PIR among Japanese patients are limited. EMOTION was a multinational study surveying insulin-using adults with T2D and initial PIR. We report a Japanese population subanalysis of EMOTION, identifying factors which help reluctant Japanese patients begin insulin therapy. Our results indicate that healthcare provider (HCP) actions are associated with a patient's decision to use insulin. Practical demonstrations by HCPs on how to use insulin were reported as most helpful. Reassurance concerning pain of injection, explanations regarding blood glucose numbers and future health, encouragement to make contact in case of any problems, and occurrence of a positive life event were also rated by Japanese participants as being helpful in deciding to commence insulin. This study provides important information on actions that can be used by HCPs to treat Japanese patients with T2D who are reluctant to begin insulin treatment. Introduction EMOTION was a multinational, noninterventional study surveying current insulin-using adults with type 2 diabetes mellitus (T2D) who were initially reluctant to begin insulin treatment. In this Japanese population subanalysis of EMOTION, we identify the frequency and level of helpfulness of healthcare provider (HCP) actions, and we analyze life events ('actions/events') that assist T2D patients with psychological insulin resistance in the decision to initiate insulin. Methods Participants were selected from Survey Sampling International and their local partners' market research panels in Japan. Quantitative surveys were administered between December 2016 and August 2017 to patients who met the study criteria. Participants were asked whether 45 actions/events occurred, and to rate the level of helpfulness of the actions/events in contributing to their decision to initiate insulin. Results Among the 594 eligible participating adults in the EMOTION study, 99 were from Japan. Despite initial reluctance to begin insulin treatment, 80.8% of the Japanese participants immediately commenced insulin. Practical demonstrations by HCPs on how to use insulin were rated by participants as most helpful. Examples of such practical demonstrations, reported as helping moderately or a lot, were 'HCP walked patient through the process of exactly how to take insulin' (82.8%), 'HCP showed an insulin pen' (79.7%), and 'HCP helped patient to see how simple it was to inject insulin' (79.1%). Conclusion This study identifies actions that HCPs can use to assist Japanese patients in deciding whether to initiate insulin. These findings may aid the development of clinical interventions addressing reluctance to begin insulin treatment among Japanese patients with T2D. Funding Eli Lilly and Company and Boehringer Ingelheim. Plain Language Summary Plain language summary available for this article.
引用
收藏
页码:1823 / 1834
页数:12
相关论文
共 50 条
  • [31] Explaining psychological insulin resistance in adults with non-insulin-treated type 2 diabetes: The roles of diabetes distress and current medication concerns. Results from Diabetes MILES-Australia
    Holmes-Truscott, E.
    Skinner, T. C.
    Pouwer, F.
    Speight, J.
    [J]. PRIMARY CARE DIABETES, 2016, 10 (01) : 75 - 82
  • [32] Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes
    Ahmann, Andrew
    Szeinbach, Sheryl L.
    Gill, Jasvinder
    Traylor, Louise
    Garg, Satish K.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (02) : 76 - 83
  • [33] 'Is Insulin Right for Me?': Web-based intervention to reduce psychological barriers to insulin therapy among adults with non- insulin- treated type 2 diabetes-A randomised controlled trial
    Holmes-Truscott, Elizabeth
    Holloway, Edith E.
    Lam, Benjamin
    Baptista, Shaira
    Furler, John
    Hagger, Virginia
    Skinner, Timothy
    Speight, Jane
    [J]. DIABETIC MEDICINE, 2023, 40 (07)
  • [34] Strategies for insulin therapy in type 2 diabetes
    Edelman, SV
    Morello, CM
    [J]. SOUTHERN MEDICAL JOURNAL, 2005, 98 (03) : 363 - 371
  • [35] Insulin strategies for type 2 diabetes mellitus
    Vivian, EM
    Olarte, SV
    Gutierrez, AM
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (11) : 1916 - 1923
  • [36] Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population
    Polonsky, William H.
    Hajos, Tibor R. S.
    Dain, Marie-Paule
    Snoek, Frank J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1169 - 1174
  • [37] Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia
    Mirahmadizadeh, Alireza
    Delam, Hamed
    Seif, Mozhgan
    Banihashemi, Sayed Aliakbar
    Tabatabaee, Hamidreza
    [J]. IRANIAN JOURNAL OF MEDICAL SCIENCES, 2019, 44 (03) : 204 - 213
  • [38] Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes
    Wen, Song
    Liu, Congying
    Li, Yanyan
    Pan, Junhong
    Thiquynhnga Nguyen
    Zhou, Ligang
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2389 - 2397
  • [39] Attitudes and beliefs of South African primary healthcare practitioners on initiating insulin in people with type 2 diabetes: Findings from the Tshwane Insulin Project (TIP)
    Piotie, Patrick Ngassa
    Wood, Paola
    Muchiri, Jane W.
    Webb, Elizabeth M.
    Rheeder, Paul
    [J]. PRIMARY CARE DIABETES, 2021, 15 (05) : 865 - 870
  • [40] Validation and application of the Insulin Treatment Appraisal Scale in Cuban patients with type 2 diabetes mellitus
    Hernandez-Garcia, Frank
    Ernesto Gonzalez-Velazquez, Victor
    Perez Garcia, Enrique Rolando
    Lazo Herrera, Luis Alberto
    Maria Pedraza-Rodriguez, Elys
    Pupo Perez, Antonio
    Gonzalez Quintana, Patricia
    Casanovas Figueroa, Jany
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2022, 69 (10): : 791 - 801